Director Johannes Schikan Sells Pharvaris N.V. Common Stock

Johannes Schikan, a director at Pharvaris N.V., has sold a total of 32,800 shares of common stock across three transactions on April 29 and April 30, 2026. These sales were executed as part of a pre-arranged Rule 10b5-1 trading plan. The sales resulted in a decrease in his post-transaction shares to 355,167. The weighted average sale prices for these transactions ranged from $30.00 to $31.05. The filing indicates that the shares sold may include those acquired upon the vesting of restricted stock units. Schikan has undertaken to provide further information on specific sale prices upon request to the SEC, the issuer, or security holders.